相关论文

Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2*

Abstract:The life-threatening complications of sepsis in humans are elicited by infection with Gram-negative as well as Gram-positive bacteria. Recently, lipopolysaccharide (LPS), a major biologically active agent of Gram-negative bacteria, was shown to mediate cellular activation by a member of the human Toll-like receptor family, Toll-like receptor (TLR) 2. Here we investigate the mechanism of cellular activation by soluble peptidoglycan (sPGN) and lipoteichoic acid (LTA), main stimulatory components of Gram-positive bacteria. Like LPS, sPGN and LTA bind to the glycosylphosphatidylinositol-anchored membrane protein CD14 and induce activation of the transcription factor NF-κB in host cells like macrophages. We show that whole Gram-positive bacteria, sPGN and LTA induce the activation of NF-κB in HEK293 cells expressing TLR2 but not in cells expressing TLR1 or TLR4. The sPGN- and LTA-induced NF-κB activation was not inhibited by polymyxin B, an antibiotic that binds and neutralizes LPS. Coexpression together with membrane CD14 enhances sPGN signal transmission through TLR2. In contrast to LPS signaling, activation of TLR2 by sPGN and LTA does not require serum. These findings identify TLR2 as a signal transducer for sPGN and LTA in addition to LPS.

参考文献

[1]  L. Larivière,et al.  Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.

[2]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[3]  M. Rothe,et al.  Human Toll-like Receptor 2 Confers Responsiveness to Bacterial Lipopolysaccharide , 1998, The Journal of experimental medicine.

[4]  G. Vogel Fly Development Genes Lead to Immune Find , 1998, Science.

[5]  A. Gurney,et al.  Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling , 1998, Nature.

[6]  S. Saccani,et al.  The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6) , 1998, The Journal of experimental medicine.

[7]  B. Trask,et al.  Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans. , 1998, Blood.

[8]  D. Golenbock,et al.  Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. , 1998, Journal of immunology.

[9]  Jiahuai Han,et al.  Cellular activation mechanisms in septic shock. , 1998, Frontiers in bioscience : a journal and virtual library.

[10]  R. Tapping,et al.  Binding of Bacterial Peptidoglycan to CD14* , 1998, The Journal of Biological Chemistry.

[11]  G. Hardiman,et al.  A family of human receptors structurally related to Drosophila Toll. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Fenton,et al.  Differential Responses of Human Mononuclear Phagocytes to Mycobacterial Lipoarabinomannans: Role of CD14 and the Mannose Receptor , 1998, Infection and Immunity.

[13]  M. Meister,et al.  Antimicrobial peptide defense in Drosophila , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  T. Kirikae,et al.  Lipopolysaccharide (LPS)-induced IL-6 production by embryonic fibroblasts isolated and cloned from LPS-responsive and LPS-hyporesponsive mice. , 1997, Molecular immunology.

[15]  Antony Rodriguez,et al.  The 18‐wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense , 1997, The EMBO journal.

[16]  D. Goeddel,et al.  Identification and Characterization of an IκB Kinase , 1997, Cell.

[17]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[18]  C. Thiemermann,et al.  Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14-dependent pathway. , 1997, Biochemical and biophysical research communications.

[19]  H. Flad,et al.  Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes , 1997, Infection and immunity.

[20]  W. Fischer,et al.  Small-angle X-ray scattering analysis of pneumococcal lipoteichoic acid phase structure. , 1997, European journal of biochemistry.

[21]  T. Kirkland,et al.  CD14 Is a Cell-activating Receptor for Bacterial Peptidoglycan* , 1996, The Journal of Biological Chemistry.

[22]  B. Lemaître,et al.  The Dorsoventral Regulatory Gene Cassette spätzle/Toll/cactus Controls the Potent Antifungal Response in Drosophila Adults , 1996, Cell.

[23]  K. Murphy,et al.  Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway , 1996, Infection and immunity.

[24]  M. Gayle,et al.  T1/ST2 Signaling Establishes It as a Member of an Expanding Interleukin-1 Receptor Family (*) , 1996, The Journal of Biological Chemistry.

[25]  C. Thiemermann,et al.  The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.

[27]  R. Ulevitch,et al.  Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. , 1995, Annual review of immunology.

[28]  V. Baichwal,et al.  Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression , 1994, Molecular and cellular biology.

[29]  R. Dziarski,et al.  Heparin, sulfated heparinoids, and lipoteichoic acids bind to the 70-kDa peptidoglycan/lipopolysaccharide receptor protein on lymphocytes. , 1994, The Journal of biological chemistry.

[30]  R. Dziarski,et al.  Isolation of peptidoglycan and soluble peptidoglycan fragments. , 1994, Methods in enzymology.

[31]  R. Bone,et al.  Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome) , 1992, JAMA.

[32]  J. Langhorne,et al.  Gamma interferon production in endotoxin-responder and -nonresponder mice during infection , 1991, Infection and immunity.

[33]  R. Dziarski Peptidoglycan and lipopolysaccharide bind to the same binding site on lymphocytes. , 1991, The Journal of biological chemistry.

[34]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[35]  I. Hilgert,et al.  Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. , 1989, Molecular immunology.

[36]  K. Anderson,et al.  Establishment of dorsal-ventral polarity in the Drosophila embryo: Genetic studies on the role of the Toll gene product , 1985, Cell.

[37]  C. Fernández,et al.  Genetic Analysis of the Low Responsiveness to Dextran B512 in CB A/N and C57BL/10ScCr Mice , 1983, Scandinavian journal of immunology.

[38]  W. Fischer,et al.  Improved preparation of lipoteichoic acids. , 1983, European journal of biochemistry.

引用
Cytokine induction by purified lipoteichoic acids from various bacterial species – Role of LBP, sCD14, CD14 and failure to induce IL‐12 and subsequent IFN‐γ release
European journal of immunology
2002
Human macrophage activation programs induced by bacterial pathogens
Proceedings of the National Academy of Sciences of the United States of America
2002
Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll‐like receptors 2, 4, and 9 in species‐specific patterns
Journal of leukocyte biology
2006
Toll-like receptors and innate immunity
Nature Reviews Immunology
2001
The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.
The Journal of infectious diseases
2002
IFNs activate toll-like receptor gene expression in viral infections
Genes and Immunity
2001
Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells*
The Journal of Biological Chemistry
2001
Response to Neisseria gonorrhoeae by Cervicovaginal Epithelial Cells Occurs in the Absence of Toll-Like Receptor 4-Mediated Signaling1
The Journal of Immunology
2002
Exercise and Toll-like receptors Running Head : Exercise and TLRs
2007
Toll-like receptors and innate immunity.
Biochemical and biophysical research communications
2009
Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens
The Journal of experimental medicine
2001
Signaling danger: toll-like receptors and their potential roles in kidney disease.
Journal of the American Society of Nephrology : JASN
2004
Two Lipoproteins Extracted from Escherichia coli K-12 LCD25 Lipopolysaccharide Are the Major Components Responsible for Toll-Like Receptor 2-Mediated Signaling1
The Journal of Immunology
2002
Extracellular Toll-Like Receptor 2 Region Containing Ser40-Ile64 but Not Cys30-Ser39 Is Critical for the Recognition ofStaphylococcus aureus Peptidoglycan*
The Journal of Biological Chemistry
2001
Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21
The Journal of Immunology
2000
Bifidobacterium breve - HT-29 cell line interaction: modulation of TNF-α induced gene expression.
Beneficial microbes
2011
Thrombospondin‐1 promotes cellular adherence of Gram‐positive pathogens via recognition of peptidoglycan
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2007
Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test.
ALTEX
2013
Induces Transcription of Interleukin-8 B Signal Transduction Pathway That κ NF- → IKK → NIK → TRAF → IRAK → MyD88 → TLR2 Micrococci and Peptidoglycan Activate
2014
Toll‐like receptors: molecular mechanisms of the mammalian immune response
Immunology
2000